BDR
Income statement / Annual
Last year (2022), Blonder Tongue Laboratories, Inc.'s total revenue was $18.12 M,
an increase of 14.99% from the previous year.
In 2022, Blonder Tongue Laboratories, Inc.'s net income was -$2.92 M.
See Blonder Tongue Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$18.12 M
|
$15.75 M
|
$16.38 M
|
$19.84 M
|
$21.71 M
|
$23.28 M
|
$22.51 M
|
$20.94 M
|
$29.13 M
|
$27.87 M
|
| Cost of Revenue |
$12.65 M |
$9.90 M |
$13.36 M |
$16.41 M |
$13.29 M |
$14.35 M |
$14.15 M |
$16.79 M |
$18.17 M |
$18.56 M |
| Gross Profit |
$5.46 M |
$5.86 M |
$3.02 M |
$3.43 M |
$8.42 M |
$8.94 M |
$8.36 M |
$4.16 M |
$10.96 M |
$9.31 M |
| Gross Profit Ratio |
0.3 |
0.37 |
0.18 |
0.17 |
0.39 |
0.38 |
0.37 |
0.2 |
0.38 |
0.33 |
| Research and Development
Expenses |
$1.78 M
|
$2.59 M
|
$2.52 M
|
$3.07 M
|
$2.58 M
|
$2.45 M
|
$2.74 M
|
$3.33 M
|
$3.42 M
|
$3.37 M
|
| General & Administrative
Expenses |
$3.82 M
|
$3.77 M
|
$5.15 M
|
$5.00 M
|
$4.24 M
|
$3.53 M
|
$3.83 M
|
$4.15 M
|
$4.77 M
|
$5.11 M
|
| Selling & Marketing
Expenses |
$2.00 M
|
$2.46 M
|
$2.46 M
|
$3.00 M
|
$2.46 M
|
$2.49 M
|
$2.46 M
|
$3.07 M
|
$3.40 M
|
$3.37 M
|
| Selling, General &
Administrative Expenses |
$5.82 M
|
$6.23 M
|
$7.61 M
|
$8.01 M
|
$6.70 M
|
$6.02 M
|
$6.29 M
|
$7.22 M
|
$8.17 M
|
$8.48 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$7.59 M |
$5.24 M |
$10.13 M |
$3.90 M |
$9.27 M |
$8.47 M |
$9.03 M |
$10.56 M |
$11.59 M |
$11.86 M |
| Cost And Expenses |
$5.06 M |
$4.65 M |
$3.23 M |
$12.51 M |
$22.56 M |
$22.82 M |
$23.18 M |
$27.34 M |
$29.76 M |
$30.42 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$789,000.00 |
$514,000.00 |
$345,000.00 |
$261,000.00 |
$0.00 |
$723,000.00 |
$0.00 |
$325,000.00 |
$242,000.00 |
$277,000.00 |
| Depreciation &
Amortization |
$891.00
|
$911,000.00
|
$1.10 M
|
$1.11 M
|
$521,000.00
|
$642,000.00
|
$972,000.00
|
$1.31 M
|
$1.42 M
|
$1.31 M
|
| EBITDA |
-$2.13 M
|
-$2.62 M
|
-$6.78 M
|
-$7.25 M
|
-$333,000.00
|
$463,000.00
|
$301,000.00
|
-$5.09 M
|
$710,000.00
|
-$1.23 M
|
| EBITDA Ratio |
-0.11 |
-0.17 |
-0.41 |
-0.37 |
-0.04 |
0.04 |
-0.01 |
-0.24 |
0.03 |
-0.04 |
| Operating Income Ratio
|
-0.12
|
-0.19
|
-0.43
|
-0.39
|
-0.04
|
0.02
|
-0.03
|
-0.31
|
-0.02
|
-0.09
|
| Total Other
Income/Expenses Net |
-$789,000.00
|
$3.06 M
|
-$345,000.00
|
$6.91 M
|
-$562,000.00
|
-$865,000.00
|
-$495,000.00
|
-$325,000.00
|
-$242,000.00
|
-$277,000.00
|
| Income Before Tax |
-$2.92 M |
$99,000.00 |
-$7.46 M |
-$727,000.00 |
-$1.42 M |
-$402,000.00 |
-$1.17 M |
-$6.73 M |
-$871,000.00 |
-$2.82 M |
| Income Before Tax Ratio
|
-0.16
|
0.01
|
-0.46
|
-0.04
|
-0.07
|
-0.02
|
-0.05
|
-0.32
|
-0.03
|
-0.1
|
| Income Tax Expense |
$0.00 |
$15,000.00 |
$15,000.00 |
$15,000.00 |
-$77,000.00 |
-$18,000.00 |
$29,000.00 |
$46,000.00 |
$31,000.00 |
$0.00 |
| Net Income |
-$2.92 M |
$84,000.00 |
-$7.47 M |
-$742,000.00 |
-$1.34 M |
-$384,000.00 |
-$1.20 M |
-$6.77 M |
-$902,000.00 |
-$2.82 M |
| Net Income Ratio |
-0.16 |
0.01 |
-0.46 |
-0.04 |
-0.06 |
-0.02 |
-0.05 |
-0.32 |
-0.03 |
-0.1 |
| EPS |
-0.22 |
0.0069 |
-0.76 |
-0.0773 |
-0.15 |
-0.0469 |
-0.16 |
-1.05 |
-0.14 |
-0.45 |
| EPS Diluted |
-0.22 |
0.0069 |
-0.76 |
-0.0773 |
-0.15 |
-0.0469 |
-0.16 |
-1.05 |
-0.14 |
-0.45 |
| Weighted Average Shares
Out |
$13.27 M
|
$12.15 M
|
$9.83 M
|
$9.60 M
|
$8.90 M
|
$8.19 M
|
$7.41 M
|
$6.46 M
|
$6.22 M
|
$6.22 M
|
| Weighted Average Shares
Out Diluted |
$13.28 M
|
$12.15 M
|
$9.90 M
|
$9.60 M
|
$8.90 M
|
$8.19 M
|
$7.41 M
|
$6.46 M
|
$6.22 M
|
$6.22 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
